RecruitingNot ApplicableNCT06181396

Time of Oxytocin Initiation at 2nd Stage of Labor and Adverse Outcomes

Association Between Time of Oxytocin Initiation at 2nd Stage of Labor and Adverse Outcomes


Sponsor

Rambam Health Care Campus

Enrollment

120 participants

Start Date

Oct 1, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Early oxytocin administration at the 2nd stage of labor is associated with a higher rate of vaginal delivery, shorter second stage duration, and fewer adverse maternal and neonatal outcomes.


Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria3

  • Singleton pregnancy
  • Maternal age ≥ 18 years' old
  • Oxytocin administration initiated or renewed during second stage of labor

Exclusion Criteria4

  • Maternal age \< 18 years' old
  • Multiple gestation pregnancy
  • Known fetal malformations
  • Uterine scar

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGOxytocin

Native oxytocin analog


Locations(1)

Rambam medical health campus

Haifa, Israel

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06181396


Related Trials